5-FLuoro-n,n-bis(propan-2-yl)-2-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

Catalog No. :
ACZWCA082
CAS No. :
2624407-79-8
Molecular Formula :
C19H29BFNO3
Molecular Weight :
349.26

IUPAC Name:5-fluoro-N,N-diisopropyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

5-FLuoro-n,n-bis(propan-2-yl)-2-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$592.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-FLuoro-n,n-bis(propan-2-yl)-2-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
IUPAC Name5-fluoro-N,N-diisopropyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
MDL No.MFCD24039562
Molecular FormulaC19H29BFNO3
Molecular Weight349.26
SMILESCC(N(C(C1=C(B2OC(C)(C(C)(O2)C)C)C=CC(F)=C1)=O)C(C)C)C
InChI KeyWUCNMUBQYJVBEZ-UHFFFAOYSA-N
SynonymBenzamide, 5-fluoro-N,N-bis(1-methylethyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;5-FLuoro-n,n-bis(propan-2-yl)-2-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
CAS No.2624407-79-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACZWCA082 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACZWCA082 route product structure diagram
    ACZWCA0822624407-79-8
Inquiry

2. ACZWCA082 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUPRQ917 route compound structure diagram
    ACUPRQ9172377607-51-5 In Stock
  4. Then
  5. ACZWCA082 route product structure diagram
    ACZWCA0822624407-79-8
Inquiry

Comments (0)